LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations
Funding Amount
Varies
Deadline
Rolling / Open
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Scientists, physicians, students, and fellows working on HER2-related lung cancer research
Overview
Geographic Scope: International (scientists around the world)
Focus Areas: Innovative therapeutic strategies for HER2-mutated and HER2-altered lung cancers
Description
Annual research award supporting innovative therapeutic approaches for treating lung cancers with HER2 mutations and/or other HER2 alterations. Recipients are selected from hundreds of applicants.
Eligibility
Open to scientists, physicians, students, and fellows working on HER2-related lung cancer research.
Contact
- Phone: (212) 588-1580
- Email: info@LCRF.org
- Mailing Address: PO Box 780990, Philadelphia, PA 19178-0990
What Lung Cancer Research Foundation actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 23
- Total given
- $2.6M
- Median grant
- $30K
- Range
- $6,405–$801K
- By dollars: Massachusetts 34%, New York 31%, Michigan 9%. Top recipient cities: Boston, MA; New York, NY; Ann Arbor, MI.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Dana-Farber Cancer Institute Inc · Boston, MA
Research
$801K
American Society of the Italian Legions of Merit · New York, NY
Research
$320K
Alumni Association of the University of Michigan · Ann Arbor, MI
Research
$231K
UCLA · Los Angeles, CA
Research
$199K
Memorial Sloan Kettering Cancer Center · New York, NY
Research
$176K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
LCRF Leading Edge Research Grant Program
Lung Cancer Research Foundation
Amount
Varies
Deadline
Rolling / Open
LCRF Minority Career Development Award (CDA) in Lung Cancer
Lung Cancer Research Foundation
Amount
Varies
Deadline
Rolling / Open
LCRF Research Grant on Prevention and Early Detection in Lung Cancer
Lung Cancer Research Foundation
Amount
Varies
Deadline
Rolling / Open
LCRF Research Grants on Overcoming Resistance in Lung Cancer
Lung Cancer Research Foundation
Amount
Up to US $150,000
Deadline
Rolling / Open
LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer
Lung Cancer Research Foundation
Amount
Varies
Deadline
Rolling / Open
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Ready to apply for LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations. Now let's win it.